Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Amy Wolbeck currently holds 14,364 shares of Intersect ENT, Inc. (XENT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Wolbeck has been a net seller of XENT stock. They have purchased $0 and sold $1.3M worth of shares.
Amy Wolbeck's most recent insider trade was on Sep 7, 2016, when they sold 8,664 shares at $0.72 per share.
Amy Wolbeck serves as Executive at Intersect ENT, Inc. (XENT). They have executed 21 insider transactions totaling $1.3M over their tenure at the company.
Amy Wolbeck holds the position of Executive at Intersect ENT, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Amy Wolbeck has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Amy Wolbeck was on Apr 13, 2015, when they sold $420.0K worth of XENT shares. This transaction involved 16,000 shares at $26.25 per share.
Amy Wolbeck currently owns 14,364 shares of Intersect ENT, Inc. (XENT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Amy Wolbeck's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Amy Wolbeck has 21 Form 4 filings on record as an insider at Intersect ENT, Inc..
Set alerts for Amy Wolbeck and 40,000+ other insiders.